PMID- 35340061 OWN - NLM STAT- MEDLINE DCOM- 20220922 LR - 20221229 IS - 1527-3350 (Electronic) IS - 0270-9139 (Print) IS - 0270-9139 (Linking) VI - 76 IP - 4 DP - 2022 Oct TI - ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson's disease. PG - 1046-1057 LID - 10.1002/hep.32484 [doi] AB - BACKGROUND AND AIMS: Wilson's disease (WD) is a rare hereditary disorder due to ATP7B gene mutation, causing pathologic copper storage mainly in the liver and neurological systems. Hepatocyte transplantation showed therapeutic potential; however, this strategy is often hindered by a shortage of quality donor cells and by allogeneic immune rejection. In this study, we aimed to evaluate the function and efficacy of autologous reprogrammed, ATP7B gene-restored hepatocytes using a mouse model of WD. APPROACH AND RESULTS: Sufficient liver progenitor cells (LPCs) were harvested by reprogramming hepatocytes from ATP7B(-/-) mice with small molecules, which exhibited strong proliferation and hepatic differentiation capacity in vitro. After lentivirus-mediated mini ATP7B gene transfection and redifferentiation, functional LPC-ATP7B-derived hepatocytes (LPC-ATP7B-Heps) were developed. RNA sequencing data showed that, compared with LPC-green fluorescent protein-Heps (LPC-GFP-Heps) with enrichment of genes that were mainly in pathways of oxidative stress and cell apoptosis, in LPC-ATP7B-Heps under high copper stress, copper ion binding and cell proliferation pathways were enriched. LPC-ATP7B-Heps transplantation into ATP7B(-/-) mice alleviated deposition of excess liver copper with its associated inflammation and fibrosis, comparable with those observed using normal primary hepatocytes at 4 months after transplantation. CONCLUSIONS: We established a system of autologous reprogrammed WD hepatocytes and achieved ATP7B gene therapy in vitro. LPC-ATP7B-Heps transplantation demonstrated therapeutic efficacy on copper homeostasis in a mouse model of WD. CI - (c) 2022 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. FAU - Cai, Hongxia AU - Cai H AD - Department of Neurology, Tong-Ren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Cheng, Xing AU - Cheng X AD - State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China. FAU - Wang, Xiao-Ping AU - Wang XP AUID- ORCID: 0000-0002-2936-5877 AD - Department of Neurology, Tong-Ren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220413 PL - United States TA - Hepatology JT - Hepatology (Baltimore, Md.) JID - 8302946 RN - 147336-22-9 (Green Fluorescent Proteins) RN - 789U1901C5 (Copper) RN - EC 7.2.2.8 (Copper-Transporting ATPases) SB - IM MH - Animals MH - Copper/metabolism MH - Copper-Transporting ATPases/genetics/metabolism MH - Disease Models, Animal MH - Genetic Therapy MH - Green Fluorescent Proteins/genetics/metabolism MH - *Hematopoietic Stem Cell Transplantation MH - Hepatocytes/metabolism MH - *Hepatolenticular Degeneration/genetics/metabolism/therapy MH - Mutation PMC - PMC9790736 COIS- Nothing to report. EDAT- 2022/03/28 06:00 MHDA- 2022/09/23 06:00 PMCR- 2022/12/25 CRDT- 2022/03/27 20:28 PHST- 2022/03/07 00:00 [revised] PHST- 2021/12/29 00:00 [received] PHST- 2022/03/25 00:00 [accepted] PHST- 2022/03/28 06:00 [pubmed] PHST- 2022/09/23 06:00 [medline] PHST- 2022/03/27 20:28 [entrez] PHST- 2022/12/25 00:00 [pmc-release] AID - HEP32484 [pii] AID - 10.1002/hep.32484 [doi] PST - ppublish SO - Hepatology. 2022 Oct;76(4):1046-1057. doi: 10.1002/hep.32484. Epub 2022 Apr 13.